Abstract. Background
Conclusion: Most eugenol-related compounds had proinflammatory activity at high concentrations. However, they had also anti-inflammatory activity at lower concentrations. Eugenol-related compounds may exert antioxidant and anti-inflammatory activity in LPS-stimulated RAW264.7 cells possibly by inhibiting the activation of nuclear factor-kappa B (Nf-ĸB), whereas bis-eugenol requires induction of HO-1 expression. bis-Eugenol as well as curcumin, may have anti-inflammatory and anticancer therapeutic applications.Eugenol-related compounds are known to have antioxidant, anti-inflammatory, antiviral, antifungal, antibacterial, anticancer, antidiabetic and neuroprotective properties (1-3). We have previously shown that the biphenols curcumin, biseugenol, magnolol and honokiol exert antioxidant effects and also inhibit the up-regulation of cyclooxygenase-2 (Cox-2) mRNA expression elicited by lipopolysaccharide (LPS) and Porphyromonas gingivalis fimbriae (PGF) (4, 5). We have also shown that the prooxidant activity of eugenol, isoeugenol and curcumin is inhibited by visible light irradiation and treatment with horseradish peroxidase, suggesting that these compounds elicit production of intracellular reactive oxygen species (ROS) under prooxidative conditions (6-8). Interestingly, low and physiological levels of ROS are required for normal physiological activity in cells, whereas high levels of ROS promote cytotoxicity, apoptosis, and inflammatory activity. A high level of ROS modulates a number of cell signaling pathways, and regulates the expression of multiple genes such as Cox-2 and nitric oxide synthase (Nos) 2 in vitro and in vivo 819